The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment

Mild Cognitive Impairment Clinical Trial

— NeuroExercise  

Official title:

The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment (MCI)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02913053
• Other study ID #: ZonMw733051044
• Secondary ID: BMBF 01ED1510AJP
• Status: Completed
• Phase: N/A
• Start date: June 2015
• Est. completion date: December 2018

Study information

• Verified date: November 2019
• Source: Radboud University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Exercise interventions to prevent dementia and delay cognitive decline have gained considerable attention in recent years. Human and animal studies have demonstrated that regular physical activity targets brain function by increasing cognitive reserve. Although initial studies indicate enhanced cognitive performance in patients with mild cognitive impairment (MCI) following an exercise intervention, little is known about the effect of an extensive, controlled and regular exercise regimen on the neuropathology of patients with MCI.

The aim of this study is to compare a 12- month aerobic exercise programme versus a stretching and toning (non-aerobic) programme versus a control group on the progression of cognitive decline in MCI.

It is hypothesized that MCI-related decreases in cognitive and psychomotor functioning will show less progression or even be improved after a one-year aerobic exercise intervention compared to a group of patients undergoing stretching and toning exercise as well as to a control group provided with no intervention.

Description:

This randomised controlled clinical intervention study will take place across three European sites; the German Sport University Cologne, Germany, University of Nijmegen, The Netherlands and Trinity College Dublin, Ireland. Seventy-five previously sedentary patients with a clinical diagnosis of MCI will be recruited at each site. Participants will be randomised to one of three intervention arms. One group will receive a standardised one-year extensive aerobic exercise intervention (3 units of 45min / week). The second group will complete stretching and toning (non-aerobic) exercise (3 units of 45min / week) and the third group will receive usual care. Change in all outcomes will be measured at baseline (T0), after six months (T1) and after 12 months (T2).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 183
• Est. completion date: December 2018
• Est. primary completion date: November 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) according to the Albert et al (2011) criteria

• Montreal Cognitive Assessment (MoCA) (Nasreddine et al. 2005) score 18-26

• Stable medical condition for more than 6 months

• Stable medications for more than 3 months

• Adequate visual and auditory acuity to complete neuropsychological testin

• Electrocardiogram without significant abnormalities that might interfere with the study

• Physical ability sufficient to allow performance of endurance exercise training

• Capacity to provide written and dated informed consent form

• Medical clearance to undergo a symptom-limited cardiopulmonary exercise test and extensive aerobic exercise training

• Participants recruited from the community via newspaper articles and community advertisement will complete additional testing to determine MCI status. Participants must score =1.5 standard deviation (SD) of cut-off scores on episodic memory test

Exclusion Criteria:

• Diagnosis of AD or other type of dementia

• History of familial early-onset dementia

• Enrollment onto any investigational drug study

• History in the past 2 years of epileptic seizures (Participants with epilepsy who have been stable off medication and seizure free for 2 years may be included)

• Any major psychiatric disorder (a clinical diagnosis of major depressive disorder, bipolar or schizophrenia)

• Past history or MRI evidence of brain damage, including significant trauma, stroke, hydrocephalus, mental retardation, or serious neurological disorder

• Carotid stent or severe stenosis

• History of myocardial infarction within previous year congestive heart failure (New York Heart Association Class II, III or IV)

• Uncontrolled hypertension or hypotension (systolic blood pressure >200 mm Hg and/or diastolic blood pressure >110 mm Hg at rest)

• Unstable cardiac, renal, lung, liver, or other severe chronic disease

• Type 2 diabetes mellitus with hypoglycemia in the last 3 months

• Significant history of alcoholism or drug abuse within last 10 years

• Significant obesity limiting active participation in the exercise program

• Engagement in moderate-intensity aerobic exercise training for more than 30 minutes, 3 times per week, during past 2 years

• History of vitamin B12 deficiency or hypothyroidism (stable treatment for at least 3 months is allowed)

• Serious or non-healing wound, ulcer, or bone fracture

Related Conditions & MeSH terms

• Cognitive Dysfunction
• Mild Cognitive Impairment

Intervention

Behavioral:
• Aerobic exercise
Patients with mild cognitive impairment will undergo a one-year aerobic exercise program of 3 units of 45 min / week
• Non-aerobic exercise
Patients with mild cognitive impairment will undergo a one-year stretching and toning (non-aerobic) exercise program of 3 units of 45 min / week

Locations

Country	Name	City	State
Germany	German Sport University	Cologne
Ireland	Trinity College Dublin	Dublin
Netherlands	Radboud University Medical Center	Nijmegen

Sponsors (5)

Lead Sponsor	Collaborator
Radboud University	German Sport University, Cologne, University Hospital, Bonn, University of Bonn, University of Dublin, Trinity College

Countries where clinical trial is conducted

Germany,  Ireland,  Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cognitive performance	Cognitive performance will be assessed by an extensive neuropsychological test battery	One year
Secondary	Global cognitive function	MoCA (Montreal Cognitive Assessment)	One year
Secondary	Cardiovascular fitness	(sub)maximal ergometer exercise test	One year
Secondary	Physical activity	Activity monitoring with accelerometers	One year
Secondary	Health related Quality of Life	Health Related Quality of Life for People with Dementia (DemQOL)	One year
Secondary	Depressive symptoms	Center for Epidemiologic Studies Depression (CES-D)	One year
Secondary	Neuroticism-Extraversion-Openness-Five Factor Inventory (NEO-FFI)	Personality traits assessment	One year
Secondary	Timed up and Go (TUG)	Frailty measurement	One year
Secondary	Hand grip strength	Frailty measurement	One year
Secondary	30 second chair stand	Frailty measurement	One year
Secondary	Epigenetics	Genotyping of the Apolipoprotein E (APOE) 4 allele in venous blood.	One year
Secondary	Brain imaging	Magnetic Resonance Imaging (MRI) scan: brain structure	6 months